The Effect of LDL557 on Improving Degenerative Arthritis in the Elderly

Chung Shan Medical University

Status: Not yet enrolling

Conditions: Arthritis; Joint Pain

Treatments: Dietary Supplement: Placebo Capsule; Dietary Supplement: LDL557-HK capsule

Study type: Interventional

Funder types: Other

Identifiers

NCT06658821

CS2-24147

Details and patient eligibility

About

This project is to conduct a clinical trial of SYNBIO TECH INC.'s LDL557 capsule for joint protection. To understand the improvement of joint discomfort and inflammation after supplementation, we hope to provide an updated choice for modern people's joint protection.

Enrollment: 100 estimated patients

Sex: All

Ages: 45 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• BMI 18-40 kg/m2;
• Those with early stage degenerative arthritis symptoms judged by X-ray to be Kellgren-Lawrence Grading Scale level 1 or 2, and the physician determines that long-term treatment is not needed or WOMAC score>2.0 or WOMAC total scale score>12 or VAS score ≦3.

Exclusion criteria

• Smoking
• alcoholism
• diabetes
• breastfeeding women and pregnant women.
• Those consuming dietary supplements were excluded.
• Those who use non-steroidal anti-inflammatory analgesics and those who have had joint surgery.
• Rheumatoid arthritis.
• Those who have had joint injections within 6 months.
• Those with cardiovascular and cerebrovascular, rheumatoid or mental diseases.
• Patients undergoing cancer treatment.

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

100 participants in 2 patient groups, including a placebo group

LDL557-HK capsule

Experimental group

Description:

Subjects will take one capsule of the experimental group(LDL557-HK capsule) within 30 minutes before lunch during the experimental period.

Treatment:

Dietary Supplement: LDL557-HK capsule

Placebo capsule

Placebo Comparator group

Description:

Subjects will take one placebo capsule within 30 minutes before lunch during the experimental period.

Treatment:

Dietary Supplement: Placebo Capsule